The global diabetes care devices market was valued at $20.0 billion in 2020, and is projected to reach $38.3 billion by 2030, growing at a CAGR of 6.6% from 2021 to 2030.
Report Code : A02507 | Pages : 180 | Category : Life Sciences
The global diabetes therapeutics market was valued at $118,063.3 million in 2020 and is projected to reach $317,915 million by 2030, growing at a CAGR of 10.4% from ...
Report Code : A03202 | Pages : 160 | Category : Life Sciences
The global diabetes drugs market was valued at $79.3 billion in 2023, and is projected to reach $157.9 billion by 2033, growing at a CAGR of 7.1% from 2024 to 2033.
Report Code : A01159 | Pages : 280 | Category : Life Sciences
The global home medical equipment market size was valued at $30,545.34 million in 2019, and is estimated to reach $56,457.87 million by 2027, registering a CAGR of 6.1% ...
Report Code : A04075 | Pages : 302 | Category : Life Sciences
The Global Gastroparesis Market was valued at $4,667 million in 2016, and is projected to reach $6,486 million at a CAGR of 4.7% from 2017 to 2023. Gastroparesis ...
Report Code : A03806 | Pages : 231 | Category : Life Sciences
The safety needles market accounted for $1,609 million in 2018, and is expected to reach $3,009 million by 2026, registering a CAGR of 8.1% from 2019 to 2026.
Report Code : A03519 | Pages : 313 | Category : Life Sciences
The global digital therapeutics market size was valued at $3,845.74 Million in 2021, and is projected to reach $22,601.97 Million by 2031, registering a CAGR of 19.4% from 2022 to 2031.
Report Code : A01787 | Pages : 300 | Category : Life Sciences
The global point of care diagnostics market was valued at $29,478.63 million in 2020 and is projected to reach $55,275.73 million by 2030, growing at a CAGR of 6.5% from 2021 to 2030.
Report Code : A00080 | Pages : 215 | Category : Life Sciences
Proteins and Peptides are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases, which can be administered orally are known as oral peptide and ...
Report Code : A00285 | Pages : 120 | Category : Life Sciences
The global diabetic retinopathy market size was valued at $3,086.00 million in 2020, and is projected to reach $10,785.50 million by 2030, registering a CAGR of 13.7% from 2021 to 2030.
Report Code : A01680 | Pages : 157 | Category : Life Sciences
The global api intermediate market was valued at $139.4 billion in 2022, and is projected to reach $285 billion by 2032, growing at a CAGR of 7.4% from 2023 to 2032.
Report Code : A02308 | Pages : 390 | Category : Life Sciences
The global smart insulin or glucose responsive insulin market size was valued at $2,773.73 million in 2019, and is expected to reach $6,174.30 million by 2027, registering a CAGR of 10.5% from 2020 to 2027.
Report Code : A01349 | Pages : 233 | Category : Life Sciences
The global antihyperlipidemic drugs market accounted for $9,456 million in 2018, and is expected to reach $16,865 million by 2026, registering a CAGR of 7.5% from 2019 to 2026.
Report Code : A05919 | Pages : 184 | Category : Life Sciences
Dialysis is a technique used to remove waste products such as urea and creatinine from blood, which occurs from inappropriate functioning of kidneys and is usually required for ...
Report Code : A03134 | Pages : 262 | Category : Life Sciences
The infusion pumps & accessories market size was valued at $8138.49 Million in 2020, and is estimated to reach $13,264.18 Million by 2030, growing at a CAGR of ...
Report Code : A00452 | Pages : 294 | Category : Life Sciences
The global cord blood banking services market was valued at $1.3 billion in 2020, and is projected to reach $4.5 billion by 2030, growing at a CAGR of 13.3% from 2021 to 2030.
Report Code : A00034 | Pages : 233 | Category : Life Sciences
The global smart insulin pens market was valued at $94.76 million in 2020, and is projected to reach $298.87 million by 2030, growing at a CAGR of 12.1% from 2021 to 2030.
Report Code : A03145 | Pages : 170 | Category : Life Sciences
The global drug-device combination products market was valued at $81,374 million in 2017 and is projected to reach $139,193 million by 2025 at a CAGR of 6.9% from ...
Report Code : A00545 | Pages : 244 | Category : Life Sciences
The global mHealth market was valued at $70.7 billion in 2022 and is projected to reach $370.7 billion by 2032, growing at a CAGR of 18% from 2023 to 2032.
Report Code : A00015 | Pages : 350 | Category : Life Sciences
The global digital diabetes management market was valued at $3,375.8 million in 2018 and is projected to reach $17,118.7 million by 2026, registering a CAGR of 22.5% from 2019 to 2026.
Report Code : A06052 | Pages : 169 | Category : Life Sciences
The global disposable incontinence products market size was valued at 7,229 million in 2018 and is expected to reach 10,544 million by 2026, registering a CAGR of 4.9% from 2019 to 2026.
Report Code : A02559 | Pages : 194 | Category : Life Sciences
The global healthcare contract research organization (CRO) services market was valued at $38,996.9 million in 2018 and is expected to reach $66,036.6 million by 2026, registering a CAGR ...
Report Code : A06078 | Pages : 182 | Category : Life Sciences
The global pharmaceutical drug delivery market was valued at $1,498.72 billion in 2022, and is projected to reach $2,307.27 billion by 2032, growing at a CAGR of 4.4% from 2023 to 2032.
Report Code : A06102 | Pages : 236 | Category : Life Sciences
The global next generation diabetes therapy and drug delivery market was valued at $7.1 billion in 2020, and is projected to reach $28.0 billion by 2030, growing at a CAGR of 14.28% from 2021 to 2030.
Report Code : A01768 | Pages : 254 | Category : Life Sciences
The Egypt medical bandages market size was valued at $14.38 million in 2018 and is expected to reach $19.12 million by 2026, registering a CAGR of 3.6% from ...
Report Code : A06117 | Pages : 86 | Category : Life Sciences
